Approved Study Database

Ref. No. Scientific Title Principal investigator
2019.577 Outcome of Prophylactic Precaesarean Iliac Artery Balloon Insertion in Patients with Abnormal Placental Implantation. Dr. TSAI Siu Chun
蔡紹俊
2019.576 Mother-to-Infant Transfer of Bacteriome, Fungome, Virome, and Metabolome in Health and Crohn's disease (MoMmy-CD) Prof. NG Siew Chien
黃秀娟
2019.575 Hong Kong Growth Study (Phases 2 and 3) Prof. NELSON Edmund Anthony Severn
2019.574 Stopping biological therapy in perianal Crohn’s disease patients with radiologically healed fistulas: a prospective cohort study Prof. MAK Wing Yan
麥詠欣
2019.573 Subclinical gut inflammation and gut microbiome in axial spondyloarthritis patients in Hong Kong Prof. TAM Lai Shan
譚麗珊
2019.572 The impact of the vitamin D status in utero, at early childhood and at adolescence on peak bone mass in young adults in Chinese Prof. WANG Chi Chiu
2019.571 Gaps In Awareness of Peripheral Arterial Disease in Hong Kong: A Cross Sectional Study Prof. YAN Bryan Ping Yen
甄秉言
2019.570 Augmented Velocity Index of intra-abdominal, carotid and retinal arteries: In relation to arterial stiffness and cardiovascular risk factors. Dr. LIU Kin Hung
廖健鴻
2019.569 Can TM4SF3 be used as novel prognostic marker and Andrographis paniculata as personalised therapy for metastatic esophageal cancer patients? Prof. LAU Clara Bik San
劉碧珊
2019.568 Centre for Novostics Prof. LO Dennis Yuk Ming
盧 煜 明
2019.567 Early Intelligent Diagnosis and Advanced Intervention for Stroke Neurorehabilitation Prof. TONG Kai Yu
湯啟宇
2019.566 Evaluation on Efficacy of Atrial Fibrillation Clinic on Optimizing Anticoagulant Usage in Non-valvular Atrial Fibrillation Patient, and Study of Epidemiology of Non-valvular Atrial Fibrillation in Hong Kong - A study in Hong Kong General Out-patient Clinic Dr. POON Wing Kwan
潘穎君
2019.565 The development and evaluation of a culturally tailored support group program on the psychosocial wellbeing of family caregivers of individuals living with dementia in Hong Kong Mr. YIU Hing Cheung
姚慶祥
2019.564 Comparative Persistence With Prolia® and Weekly Alendronate in 6 Asia-Pacific countries: a Prospective Observational Study Prof. KWOK Timothy Chi Yui
郭志銳
2019.563 Model establishment for metastasis prediction and identification of preventive herbal medicine in colorectal cancer using patient-derived xenografts Dr. YUE Grace Gar Lee
余嘉莉
2019.561 Endoscopic closure of mucosal defect after high-risk gastric endoscopic submucosal dissection (ESD) - a pilot study Dr. YIP Hon Chi
葉瀚智
2019.560 Validity of the JC Physical Activity Tracker for detecting PA energy expenditure in Chinese adults Prof. HUI Stanley Sai Chuen
許世全
2019.558 DeFect cLOsure After colonic ESD with underwaTer technique versus conventional clip : a randomized controlled trial (FLOAT trial) Dr. YIP Hon Chi
葉瀚智
2019.557 Malnutrition risk, nutrition intakes and clinical outcomes of Chronic Obstructive Pulmonary Disease (COPD) inpatients Dr. TING Terry Ho Yan
丁浩恩
2019.556 A multiple health risk assessment using automatic retinal image analysis (ARIA) for the community. Prof. ZEE Benny Chung Ying
徐仲鍈
2019.555 A Phase Ia/Ib, Open-Label, Dose-Escalation and Dose-Expansion Study of the Anti-CTLA-4 Monoclonal Antibody CS1002 as Monotherapy and in Combination with Anti-PD-1 Monoclonal Antibody CS1003 in Subjects with Advanced Solid Tumors Dr. CHAN Stephen Lam
陳林
2019.554 A Phase 1, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 in Subjects of Chinese Descent With Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation (CodeBreaK 105) Dr. LOONG Herbert Ho Fung
龍浩鋒醫生
2019.553 AXEL: Axitinib-Avelumab combination in recurrent or metastatic nasopharyngeal cancer: a multicenter phase 2 trial Prof. CHAN Anthony Tak Cheung
陳德章
2019.551 A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF INAVOLISIB PLUS PALBOCICLIB AND FULVESTRANT VERSUS PLACEBO PLUS PALBOCICLIB AND FULVESTRANT IN PATIENTS WITH PIK3CA-MUTANT, HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER Prof. YEO Winnie
楊明明 教授
2019.550 CATALYST 207: A PHASE 2, PILOT, EXPLORATORY STUDY EVALUATING THE SAFETY AND ANTIVIRAL EFFICACY OF INARIGIVIR SOPROXIL IN NON-CIRRHOTIC TREATMENT-NAÏVE SUBJECTS INFECTED WITH CHRONIC HEPATITIS B VIRUS Dr. HUI Aric Josun
許祖紳醫生
2019.549 ExtraVascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Study Dr. CHAN Joseph Yat Sun
陳日新
2019.548 The outcome of infant with biliary atresia after Kasai portoenterostomy: A 10-year retrospective study. Dr. CHAN Edwin Kin Wai
陳健維
2019.547 Safety and Effectiveness IDE trial for Boston Scientific’s Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation (FROzEN-AF) Dr. CHAN Joseph Yat Sun
陳日新醫生
2019.546 Epidemiology of sexually acquired hepatitis C virus infection in people living with HIV/AIDS in the Asia Pacific Dr. LEE Shui Shan
李瑞山
2019.545 Study for Monitoring Antimicrobial Resistance Trends (SMART) Prof. IP Margaret
2019.544 Validation study on predictive model to lower limb growth at peripubertal period in paediatric populations for management with leg length discrepancy Dr. HUNG Alec Lik Hang
洪力恆
2019.543 Pneumonia dosing in critically ill patients: a prospective cohort study Dr. LING Lowell
2019.542 The diagnostic significance of CDH17-positive circulating tumor cells in patients with colorectal cancer Prof. WONG Cesar Sze Chuen
黃思銓
2019.541 A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients with Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1) Dr. LOONG Herbert Ho Fung
龍浩鋒
2019.540 A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). Dr. TAM Lai Shan
譚麗珊
2019.539 Eating-related distress and depression in advanced cancer patients with anorexia-cachexia symptoms: A cross-sectional survey Dr. NATARAJAN Deepa
2019.538 The therapeutic effect of a combined therapy of Tui-na and oral Chinese medicine on Osteoarthritis of Knee - A randomized wait-list controlled trial Prof. LIN Zhixiu
林志秀
2019.537 Counselling in Community Psychiatric Service - Clinical Practicum for The University of Hong Kong Master of Social Science (Counselling) Ms. YEUNG Hei Wun
2019.536 In-situ Decompression Versus Decompression and Medial Epicondylectomy for the Treatment of Cubital Tunnel Syndrome - A Prospective Randomized Single-Blinded Controlled Trial Dr. KOO Jeffrey Justin Siu Cheong
古兆昌
2019.535 Music as an Adjunct for Pain and Anxiety Relief during Urological Procedure: A Randomized Control Trial Dr. YEE Chi Hang
余知行
2019.534 To investigate the effect of central arterial stiffness on the progression of male bladder dysfunction, nocturia and lower urinary tract symptoms Prof. NG Chi Fai
吳志輝
2019.533 Photoneuromodulation for Improving Mood and Memory in Adults Dr. CHAN Agnes Sui Yi
陳瑞燕
2019.532 Evaluation of the effectiveness of acupuncture at L.I.11 Quchi acupoint on knee pain in Hong Kong distance runners: A randomized controlled trial Ms. Chan Ho Yan
陳可昕
2019.531 Comparison of Effectiveness of Ear Syringing with or without Pre-Ear Oil Application , non-randomized control trial. Dr. CHANG Wells
張仕偉
2019.530 A prosective, multicentric, single arm study to evaluate the safety and efficacy of the UNITY-B Biodegradable Ballon-Expandable Biliary Stent System in subjects with biliary strictures. Prof. TEOH Anthony Yuen Bun
張源斌
2019.528 Stratification of Indolent Versus Aggressive Prostate Cancer plus the Determination of Druggable Gene Targets for Aggressive Prostate Cancer: A Retrospective Study Using Archival Biopsy Samples Dr. POON Darren M.C.
2019.527 Risk assessment and prevention of thrombosis in systemic lupus erythematosus with anti-Phospholipid antibodies Dr. YEUNG Lam Fung
楊臨鋒
2019.526 Development of Low-cost Label-free Image Cytometer based on Quantitative Phase Microscopy Prof. TANG Nelson Leung Sang
2019.525 Does Anterior Cruciate Ligament Reconstruction (ACLR) really increase osteoarthritis from Oxford criteria perspective? Dr. LAU Lawrence Chun Man
2019.524 Bayer 20810 - A Phase 1/2 Study of the TRK Inhibitor Selitrectinib (BAY 2731954) in Adult and Pediatric Subjects with Previously Treated NTRK Fusion Cancers Formerly: LOXO-EXT-17005 - A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects with Previously Treated NTRK Fusion Cancers Dr. LOONG Herbert Ho Fung

Page 74 of 262.